Germany: reliable data on MS incidence available from 2-year study:
This article was originally published in Clinica
Executive Summary
The German population of multiple sclerosis sufferers is currently 120,000, with 2,500 new cases recorded every year. The economic costs are some euro500m ($585m) per year in direct hospital costs and a further euro3.5bn in social benefits and other costs. A study led by Dr Peter Flachenecker, of the university hospital of Wurzburg set out to log patients at five regional centres over a two-year period, ending in December 2003. Their documentation project covered some 3,400 patients during this period allowing them to calculate new incidence as being 3 per 100,000 of population (based on observations in Rostock and Wurzburg). Newly-diagnosed MS patients were on average 30 years old. The project also revealed that two-thirds of observed patients were female; a third had limited mobility; 7% were wheelchair-bound; 1.6% were bed-bound. The register has since grown to 10,000 cases, and neurologists hope the knowledge put into this developing database will help in the management and therapy of patients.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.